CompletedNot Applicable

Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors

United States15 participantsStarted 2025-05-14

Plain-language summary

This study is testing a program called Maximizing Energy to see if it can help women who have finished breast cancer treatment manage their fatigue. The study has two main goals: 1. Check if the program can be successfully delivered - Researchers will see if women are willing to join and stay in the study, if they follow the program, and if they find it helpful. 2. See if the program works - Researchers will compare Maximizing Energy to a general health education program to see which one helps reduce cancer-related fatigue better. Participant will: 1. Take tests to see if they qualify and to measure their fatigue. 2. Be randomized to receive Maximizing Energy or Health Education Interventions for 6 sessions over the internet 3. After the sessions and again one month later, repeat some tests to see if their fatigue has improved.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult (18 years and older) pre and post-menopausal female at birth diagnosed with Stages I-IIIa breast cancer, * completed primary treatment for breast cancer (surgery, chemotherapy, radiation) at least 6 months prior to ensure that fatigue is stable and chronic, - moderate to severe fatigue based on score ≥ 4 on the 7-point Fatigue Severity Scale, * able to speak and understand English * has a mobile device that runs on the Apple or Android platform Exclusion Criteria: * major depressive disorder, mania, hypomania, psychosis, or substance abuse in the past 3 months and * disability due to diagnoses other than breast cancer.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Retention in the study

Timeframe: Baseline to Week 11 (4 weeks post-intervention)

Participant Adherence to treatment: Receipt

Timeframe: Week 7 (post-6-week intervention)

Participant Adherence to treatment: Receipt

Timeframe: Week 7 (post-6-week intervention)

Participant Adherence to treatment: Enactment

Timeframe: Week 7(post-6-week intervention)

Participant Satisfaction with Intervention

Timeframe: Week 7(post-6-week intervention)

Intervention Fidelity

Timeframe: Week 7(post-6-week intervention)

Changes in fatigue

Timeframe: Baseline to Week 11 (4 weeks post-intervention)

Trial details

NCT IDNCT06879522

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-23

View on ClinicalTrials.gov More Breast Cancer Survivor trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Retention in the study

Timeframe: Baseline to Week 11 (4 weeks post-intervention)

Participant Adherence to treatment: Receipt

Timeframe: Week 7 (post-6-week intervention)

Participant Adherence to treatment: Receipt

Timeframe: Week 7 (post-6-week intervention)

Participant Adherence to treatment: Enactment

Timeframe: Week 7(post-6-week intervention)

Participant Satisfaction with Intervention

Timeframe: Week 7(post-6-week intervention)

Intervention Fidelity

Timeframe: Week 7(post-6-week intervention)

Changes in fatigue

Timeframe: Baseline to Week 11 (4 weeks post-intervention)